Market Research Logo

Europe Obesity Epidemiology and Patient Flow Analysis - 2017

Europe Obesity Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Obesity patients study in a new report ‘Europe Obesity Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Obesity epidemiology, Obesity diagnosed patients, and Obesity treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Obesity derived from epidemiological analysis, percentage of patients diagnosed with Obesity, and percentage of patients treated with a therapy.

The study helps executives estimate Obesity market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Obesity prevalence, Obesity diagnosis rate, and Obesity treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Obesity Patient Flow
  • Obesity Prevalence
  • Obesity Diagnosed Patients
  • Obesity Treated Patients


1. Obesity: Disease Definition
2. Obesity Patient Flow in Europe
2A. Obesity Prevalence in Europe
2B. Obesity Diagnosed Patients in Europe
2C. Obesity Treated Patients in Europe
3. Obesity Patient Flow in Germany
3A. Obesity Prevalence in Germany
3B. Obesity Diagnosed Patients in Germany
3C. Obesity Treated Patients in Germany
4. Obesity Patient Flow in France
4A. Obesity Prevalence in France
4B. Obesity Diagnosed Patients in France
4C. Obesity Treated Patients in France
5. Obesity Patient Flow in Spain
5A. Obesity Prevalence in Spain
5B. Obesity Diagnosed Patients in Spain
5C. Obesity Treated Patients in Spain
6. Obesity Patient Flow in Italy
6A. Obesity Prevalence in Italy
6B. Obesity Diagnosed Patients in Italy
6C. Obesity Treated Patients in Italy
7. Obesity Patient Flow in UK
7A. Obesity Prevalence in UK
7B. Obesity Diagnosed Patients in UK
7C. Obesity Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Obesity Patient Flow in Europe, 2016
Table 2: Obesity Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Obesity Patient Flow in Germany, 2016
Table 4: Obesity Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Obesity Patient Flow in France, 2016
Table 6: Obesity Patient Flow Forecast in France, 2016 - 2025
Table 7: Obesity Patient Flow in Spain, 2016
Table 8: Obesity Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Obesity Patient Flow in Italy, 2016
Table 10: Obesity Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Obesity Patient Flow in UK, 2016
Table 12: Obesity Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Obesity Patient Flow in Europe, 2016
Figure 2: Obesity Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Obesity Patient Flow in Germany, 2016
Figure 4: Obesity Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Obesity Patient Flow in France, 2016
Figure 6: Obesity Patient Flow Forecast in France, 2016 - 2025
Figure 7: Obesity Patient Flow in Spain, 2016
Figure 8: Obesity Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Obesity Patient Flow in Italy, 2016
Figure 10: Obesity Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Obesity Patient Flow in UK, 2016
Figure 12: Obesity Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report